Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.1%

8 terminated/withdrawn out of 257 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

10%

26 trials in Phase 3/4

Results Transparency

5%

5 of 100 completed trials have results

Key Signals

33 recruiting5 with results4 withdrawn

Enrollment Performance

Analytics

N/A
116(65.2%)
Phase 2
20(11.2%)
Phase 3
19(10.7%)
Phase 1
14(7.9%)
Phase 4
7(3.9%)
Early Phase 1
2(1.1%)
178Total
N/A(116)
Phase 2(20)
Phase 3(19)
Phase 1(14)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (257)

Showing 20 of 257 trials
NCT07568626Recruiting

Factors for Prolonged Hospital Stays in Patients Undergoing ERCP

Role: lead

NCT07683936Early Phase 1Recruiting

Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery

Role: lead

NCT06031012Phase 3Completed

Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis

Role: lead

NCT07666256Not ApplicableNot Yet Recruiting

Mesenteric Vein Access for OPVT-Related Recurrent Variceal Bleeding: An Ambispective Cohort

Role: lead

NCT07649811Not Yet Recruiting

Endoscopic vs Non-endoscopic Drainage for Benign Gallbladder Diseases in High-risk Patients or Patients Desiring Gallbladder Preservation

Role: lead

NCT07071441Not ApplicableRecruiting

Indomethacin vs Diclofenac for Preventing PEP

Role: lead

NCT07253389Not ApplicableRecruiting

Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis

Role: lead

NCT05513040Completed

Clinical Course of Functional Dyspepsia and Factors Predicting Outcome in Patients Receiving Medication-based Treatment

Role: lead

NCT07622719Completed

Survey on Knowledge and Acceptance of Dental General Anesthesia for Children Among Different Populations

Role: lead

NCT07610551Recruiting

Efficacy and Safety of SIRT-Y90 in Combination With Atezo + Bev for Unresectable Hepatocellular Carcinoma

Role: lead

NCT07577245Not ApplicableNot Yet Recruiting

Surgical Robot or Static Guide for Dental Implant Placement

Role: collaborator

NCT07569679Phase 2Recruiting

Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

Role: lead

NCT07553780Recruiting

Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer

Role: collaborator

NCT07553754Recruiting

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Role: collaborator

NCT07157618Recruiting

Prospective Pathology Foundation Models

Role: collaborator

NCT07535138Early Phase 1Not Yet Recruiting

Efficacy and Safety of CD19 CAR-γδ T Cells in the Treatment of Relapsed/Refractory Autoimmune Nephropathy

Role: lead

NCT07531329Recruiting

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

Role: collaborator

NCT06084819Phase 2Recruiting

Clinical Study of Venetoclax Combined With CACAG Regimen in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Role: collaborator

NCT06998784Not ApplicableCompleted

Effect of Transcutaneous Auricular Vagal Nerve Stimulation on Acute Pancreatitis

Role: lead

NCT07492927Recruiting

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Role: collaborator